A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review
- PMID: 37272767
- PMCID: PMC10422061
- DOI: 10.1002/mgg3.2222
A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review
Abstract
Background: Frontotemporal dementia (FTD) has genetic heterogeneity, and the endosomal ESCRTIII-complex subunit CHMP2B variant is a rare cause of FTD. The mutations in CHMP2B were first identified in a large Danish pedigree with autosomal dominant FTD, and have also been found in several individuals from Belgium, France, the United States, and Türkiye. In the Chinese population, cases of CHMP2B variant-associated FTD have never been reported.
Methods: The spectrum of clinical symptoms and the genetic analysis of the presented patient were identified and investigated. Besides this case, we assessed previously reported cases with CHMP2B gene mutations.
Results: This study presents a Chinese patient harboring a novel heterozygous A-to-T variant (NM_014043:c.532-2A>T) in CHMP2B with a phenotype compatible with FTD. Although previous reports suggested cases of CHMP2B variant-associated FTD initially presented with personality changes and stereotypical movements at the age of 50, this case was characterized by psychosis involving delusion of persecution, auditory hallucination, and suspiciousness at the earlier onset age of 44. Minigene splicing assay revealed that the splice-site variant could result in the retention of intron 5.
Conclusion: This is the first case of CHMP2B variant-associated FTD reported in the Chinese population. The novel c.532-2A>T variant in the acceptor splice site of exon 6 retaining intron 5 was predicted to cause truncated protein and protein conformation changes. This discovery may expand the genetic and phenotypic spectrum of CHMP2B variant-associated FTD.
Keywords: CHMP2B; exon 6; frontotemporal dementia (FTD); novel variant; splice.
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.Acta Neurol Scand. 2022 May;145(5):529-540. doi: 10.1111/ane.13578. Epub 2022 Jan 8. Acta Neurol Scand. 2022. PMID: 34997757
-
Frontotemporal dementia caused by CHMP2B mutations.Curr Alzheimer Res. 2011 May;8(3):246-51. doi: 10.2174/156720511795563764. Curr Alzheimer Res. 2011. PMID: 21222599 Free PMC article. Review.
-
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.Nat Genet. 2005 Aug;37(8):806-8. doi: 10.1038/ng1609. Epub 2005 Jul 24. Nat Genet. 2005. PMID: 16041373
-
Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.Hum Mol Genet. 2017 Mar 1;26(5):873-887. doi: 10.1093/hmg/ddx003. Hum Mol Genet. 2017. PMID: 28093491 Free PMC article.
-
Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.Neurobiol Dis. 2021 Jan;147:105144. doi: 10.1016/j.nbd.2020.105144. Epub 2020 Nov 2. Neurobiol Dis. 2021. PMID: 33144171 Review.
Cited by
-
Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach.Brain Sci. 2023 Oct 18;13(10):1474. doi: 10.3390/brainsci13101474. Brain Sci. 2023. PMID: 37891841 Free PMC article. Review.
References
-
- Alqabandi, M. , de Franceschi, N. , Maity, S. , Miguet, N. , Bally, M. , Roos, W. H. , Weissenhorn, W. , Bassereau, P. , & Mangenot, S. (2021). The ESCRT‐III isoforms CHMP2A and CHMP2B display different effects on membranes upon polymerization. BMC Biology, 19(1), 66. 10.1186/s12915-021-00983-9 - DOI - PMC - PubMed
-
- Artan, S. , Erzurumluoglu Gokalp, E. , Samanci, B. , Ozbabalik Adapinar, D. , Bas, H. , Tepgec, F. , Qomi Ekenel, E. , Cilingir, O. , Bilgic, B. , Gurvit, H. , Hanagasi, H. A. , Kocagil, S. , Durak Aras, B. , Uyguner, O. , & Emre, M. (2021). Frequency of frontotemporal dementia‐related gene variants in Turkey. Neurobiology of Aging, 106, 332–332.e11. 10.1016/j.neurobiolaging.2021.05.007 - DOI - PubMed
-
- Cannon, A. , Baker, M. , Boeve, B. , Josephs, K. , Knopman, D. , Petersen, R. , Parisi, J. , Dickison, D. , Adamson, J. , Snowden, J. , Neary, D. , Mann, D. , Hutton, M. , & Pickering‐Brown, S. M. (2006). CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neuroscience Letters, 398(1–2), 83–84. 10.1016/j.neulet.2005.12.056 - DOI - PubMed
-
- Ferrari, R. , Kapogiannis, D. , Huey, E. D. , Grafman, J. , Hardy, J. , & Momeni, P. (2010). Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia. Alzheimer Disease and Associated Disorders, 24(4), 397–401. 10.1097/WAD.0b013e3181df20c7 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources